SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Lövborg Henrik)
 

Search: WFRF:(Lövborg Henrik) > Stetefeld Jörg > Utilization of a ri...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Utilization of a right-handed coiled-coil protein from archaebacterium Staphylothermus marinus as a carrier for cisplatin

Eriksson, Mathilda (author)
Karolinska Institutet
Hassan, Saadia (author)
Uppsala universitet,Klinisk farmakologi,Cancer Pharmacology and Informatics
Larsson, Rolf (author)
Uppsala universitet,Klinisk farmakologi,Cancer Pharmacology and Informatics
show more...
Linder, Stig (author)
Karolinska Institutet
Ramqvist, Torbjörn (author)
Karolinska Institutet
Lövborg, Henrik (author)
Vikinge, Trine (author)
Figgemeier, Egbert (author)
Müller, Jürgen (author)
Stetefeld, Jörg (author)
Dalianis, Tina (author)
Karolinska Institutet
Ozbek, Suat (author)
show less...
 (creator_code:org_t)
2009
2009
English.
In: Anticancer Research. - 0250-7005 .- 1791-7530. ; 29:1, s. 11-18
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: The nano-sized right-handed coiled-coil (RHCC) protein, originating from the archaebacterium Staphylothermus marinus, is stable at high salt concentrations, high temperatures, high pressures and extremes of pH. Its crystal structure reveals four hydrophobic cavities which can incorporate heavy metals. Nano-sized compounds have been used to carry cytotoxic drugs to tumours, avoiding delivery to healthy tissue, in part due to enhanced permeability in tumour blood vessels (enhanced permeability and retention effect). MATERIALS AND METHODS: The ability of RHCC to carry the platinum-containing chemotherapeutic drug cisplatin to cells, while retaining the cytotoxic potential was tested both in vitro and in vivo. RESULTS: RHCC was able to bind and enter cells in vitro and was not severely toxic or immunogenic in mice. Moreover, RHCC incorporated cisplatin, without inhibiting the cytotoxic potential of the drug against tumour cell lines in vitro or in vivo. CONCLUSION: RHCC can be used as a carrier of cisplatin without abrogating the effect of the drug.

Keyword

RHCC
cisplatin
nano
carrier
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view